Navigation Links
Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment
Date:6/17/2008

t be used to prevent diaper rash nor used for longer than 7 days because preventative use may not allow the treatment to work as well over time. If irritation occurs, or if the rash worsens, stop treatment and contact your healthcare provider.

About Barrier Therapeutics

Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(R) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis; Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment, for diaper dermatitis complicated by documented candidiasis; and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical Solution, for solar lentigines. Barrier Therapeutics has other product candidates in various stages of clinical development for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin allergies, and superficial fungal infections. The company is headquartered in Princeton, New Jersey and has a wholly-owned subsidiary in Geel, Belgium. More information about Barrier Therapeutics can be found on its corporate website at: http://www.barriertherapeutics.com.

Xolegel, Vusion and Solage are registered trademarks of Barrier Therapeutics, Inc.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

Contact: Barrier Therapeutics, Inc. 1-866-440-5508,

Kelly Sutt, 609-945-1235, ksutt@barriertherapeutics.com

Ruder Finn, Christoph Miller, 212-593-6495,

millerc@ruderfinn.com


'/>"/>
SOURCE Barrier Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Philadelphia Washed-Up ... Region Near Bottom
2. Bottomless bowls are an Ig Nobel winner
3. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
4. Eularis Releases Update of Its Comprehensive Report on Maximizing the Bottom Line in Pharmaceutical Marketing
5. Free White Paper From The Beryl Institute Quantifies Bottom-Line Impact of Corporate Culture
6. Using Early Stage Commercialization Activities to Build Long-Term Success for the Bottom Line
7. Report: Life And Death Differences in U.S. Child Well-Being Exist Between Top and Bottom States, Youths Up to Three Times More Likely to Die Before Adulthood in Some Parts of U.S.
8. Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
11. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Sunday 31 August 2014: Mortality and morbidity of ... despite good use of oral anticoagulants, according to the ... Pilot Registry. The findings were presented for the first ... Professor Gregory Lip (Birmingham, UK). , Professor Lip said: ... on management practices of European cardiologists conducted since the ...
(Date:8/30/2014)... Spain Sunday 31 August 2014: A new ... and powered by heart motion was presented at ... Switzerland. The prototype device does not require battery ... the Cardiovascular Engineering Group at ARTORG, University of ... in today,s medical implants. Once they reach a ...
(Date:8/30/2014)... In a world where a typical response to conflict is ... a game app to teach another way. Launched in ... is a colorful way to encourage moral values playfully. ... double-duty by teaching players new ways to find happiness and ... for consistently taking the high road, the Ultimate Karma game ...
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis Automotive joined ... awareness for ALS by participating in the popular ALS ... Vice President Jimmy Ellis all participated in the challenge ... on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . , In ... staff also took the opportunity to challenge various businesses ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 The ... modeling the body that will reveal to users some shocking ... lead to great results in modeling looks, as well as ... the new method says that there is one unique trick ... new method indicates that despite what many people might think, ...
Breaking Medicine News(10 mins):Health News:AF mortality and morbidity high at 1 year despite good anticoagulant use 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2
... AND EFFECTIVE FOR COPD , Previous research has ... risk for adverse events or respiratory-related death in patients ... (COPD); however, a recent article shows this may not ... Spain, Argentina, and Uruguay reviewed the results of 27 ...
... research suggests that high-risk women with breast cancer who do ... for developing a second breast cancer than previously thought. ... sentinel node biopsy be considered at the time of prophylactic ... findings? , The increased risk of developing breast cancer ...
... could help bridge this knowledge gap, experts say , , ... of babies have a surprisingly low knowledge of child ... know or how they should act, a new study ... parents don,t know that 1-year-olds can,t tell the difference ...
... hospitalizing young children for influenza creates a significant economic ... preventive flu shots for children and the people with ... by Cincinnati Childrens Hospital Medical Center and presented May ... Honolulu, Hawaii. , After analyzing data in three U.S. ...
... surprisingly low-level knowledge of typical infant development and ... emotional growth, according research from the University of ... false parenting assumptions can not only impair parent-child ... stimulation, will be presented Sunday, May 4, at ...
... designed to block the neurotransmitter acetylcholine including common ... are more likely to be dependent in one or ... according to new findings from researchers at Wake Forest ... which involve a class of drugs known as anticholinergic ...
Cached Medicine News:Health News:News briefs: May issue of the journal Chest 2Health News:Second breast cancer may be greater than thought for high-risk women without BRCA mutations 2Health News:One-Third of Parents Lack Facts About Child Development 2Health News:One-Third of Parents Lack Facts About Child Development 3Health News:Young children hospitalized for flu associated with higher costs and higher risk illness 2Health News:Nearly one-third of US parents don't know what to expect of infants 2Health News:Commonly used medications associated with impaired physical function in older adults 2
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014 Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in the 2014 Morgan Stanley Global Healthcare Conference ... Burbach , President and Chief Executive Officer, will provide ... Eastern Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3US CNS Disorders Drug Pipeline Insight 2014 2
... The annual meeting of the Chinese food industry is ... June, heavily focusing on the growing health market in China, and ... and discuss business developments in the country and beyond. ... and China continues to enjoy a global reputation for being a ...
... Amgen (Nasdaq: AMGN ) today announced the ... compared XGEVA ™ (denosumab) to Zometa ® (zoledronic ... 1,901 men with prostate cancer and bone metastases. The study, ... secondary endpoints and demonstrated XGEVA,s superiority compared to Zometa in ...
Cached Medicine Technology:Health on the Agenda at Food ingredients Asia-China Trade Show 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: